Skip to content
Clinical Trials – home

Wroclawskie Centrum Zdrowia Samodzielny Publiczny Zaklad Opieki Zdrowotnej

Research site

Poland Ul Wszystkich Swietych 2, 50-136 Wroclaw, Poland

  • 2 trials recruiting
  • HIV infection
  • Adult patients

About Specializations

Wroclawskie Centrum Zdrowia Samodzielny Publiczny Zaklad Opieki Zdrowotnej in Wroclaw, Poland specialises in clinical trials of conditions such as HIV infection, and other specialisations. This site conducts important research.

Main research areas of the site

Virus Diseases and HIV Research

At Wroclawskie Centrum Zdrowia Samodzielny Publiczny Zaklad Opieki Zdrowotnej in Wroclaw, the clinical trial portfolio focuses on Virus Diseases, with a strong emphasis on HIV-1 infection. The studies are designed to assess new and existing treatment approaches for people living with HIV, with attention to both safety and how well the therapies control the virus.

  • Evaluating the safety and tolerability of a doravirine and islatravir combination for people with prior treatment experience
  • Comparing antiretroviral effectiveness in HIV-1 infection for patients starting therapy
  • Assessing whether treatment helps achieve and maintain low HIV-1 RNA levels

The research at this Poland site supports better treatment options for HIV by combining efficacy evaluation with careful monitoring of tolerability and overall patient safety.

Antiretroviral Treatment Studies

This hospital and clinic site is conducting focused clinical research in infectious diseases, centered on HIV-1. The trials explore whether newer antiretroviral regimens can improve viral suppression while remaining safe and well tolerated for different patient groups.

  • Testing a treatment option for people who have previously received antiretroviral therapy
  • Studying first-line therapy choices for individuals newly starting HIV treatment
  • Comparing outcomes against an established regimen to understand relative effectiveness

The work at this health care facility contributes to ongoing efforts to refine HIV therapy and improve long-term disease control.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul Wszystkich Swietych 250-136 WroclawPoland
Recruiting now
2 trials
Conditions studied
1

More sites in WroclawPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

7 clinical trials

HIV infection

Recruiting

Switching to Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults with HIV-1: A Phase 3 Randomized Study

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Abacavir
  • Sponsor:Gilead Sciences Inc.

HIV infection

Recruiting

A study testing VH4524184 with emtricitabine and tenofovir alafenamide compared to dolutegravir and lamivudine in adults with HIV-1 who have not received treatment before

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Dolutegravir Sodium
  • Sponsor:Viiv Healthcare UK Limited

HIV infection

Not yet recruiting

Safety and efficacy of GS-3242 drug combination compared with standard drug combination in treatment‑naive adults with HIV‑1

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bictegravir
  • Sponsor:Gilead Sciences Inc.

HIV infection

Not yet recruiting

Study on HIV-1 Treatment for Patients New to Therapy: Comparing Doravirine/Islatravir with a Drug Combination

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bictegravir
  • Sponsor:Merck Sharp & Dohme LLC

HIV infection

Not yet recruiting

Study on Doravirine and Islatravir for People with HIV-1 Previously Treated with the Same Drug Combination

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Doravirine
  • Sponsor:Merck Sharp & Dohme LLC

HIV infection

Not recruiting

Study Comparing Weekly Islatravir/Lenacapavir Regimen to Standard Care in HIV Patients with Controlled Viral Load

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Abacavir
  • Sponsor:Gilead Sciences Inc.

HIV infection

Not recruiting

Study Comparing Dolutegravir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide for HIV Treatment in Adults New to Antiretroviral Therapy

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bictegravir
  • Sponsor:Viiv Healthcare UK Limited
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.